biosimilar cancer drug

Cadila Pharmaceuticals expand oncology portfolio with biosimilar cancer drug Bevaro™

New Delhi, July 22, 2020: Ahmedabad-based Cadila Pharmaceuticals Limited recently announced the launch of Bevasizumab biosimilar for domestic market. Bevasizumab biosimilar…

4 years ago